A cost-benefit analysis of intensive therapy

Area of Science:

• Critical Care Medicine
• Health Economics

Background:

• Intensive therapy units (ITUs) provide critical care, but patient costs vary significantly.
• Understanding cost drivers is essential for resource allocation and healthcare management.

Purpose of the Study:

• To analyze the daily costs of critically ill patients in an ITU.
• To identify factors influencing cost variations, including patient outcomes and diagnoses.

Main Methods:

• Individual patient cost data was collected for 90 critically ill patients.
• Patient survival status and diagnoses were recorded.
• Statistical analysis was performed to compare costs between survivors and nonsurvivors and identify cost-related factors.

Main Results:

• Mean daily costs for nonsurvivors (816 pounds) were substantially higher than for survivors (550 pounds).
• Renal failure, sepsis, and pneumonia were identified as high-cost conditions, whereas postoperative respiratory failure was less expensive.
• The APACHE II score on admission was a significant predictor of first-day management costs.

Conclusions:

• Significant cost variations exist within ITU patient populations.
• Patient outcomes and specific diagnoses are key determinants of overall treatment expenditure.
• APACHE II scores can help predict initial ITU costs, aiding in financial planning.